Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial

Xu, PP; Fu, D; Li, JY; Hu, JD; Wang, X; Zhou, JF; Yu, H; Zhao, X; Huang, YH; Jiang, L; Liu, F; Su, LP; Chen, ZW; Zeng, QS; Chen, JP; Fang, MY; Ma, J; Liu, T; Song, YP; Yu, K; Li, Y; Qiu, LG; Chen, XQ; Gu, J; Yon, JS; Hou, M; Huang, HY; Wang, L; Cheng

Zhao, WL (reprint author), Shanghai Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom, Shanghai 200025, Peoples R China.

LANCET HAEMATOLOGY, 2019; 6 (6): E328

Abstract

Background Anthracycline dose optimisation in the treatment of diffuse large B-cell lymphoma has rarely been tested. We aimed to find out whether R-CE......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索